Viewing Study NCT04352205


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-01-25 @ 3:35 PM
Study NCT ID: NCT04352205
Status: TERMINATED
Last Update Posted: 2024-07-01
First Post: 2020-04-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
Sponsor: Emory University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: STUDY00000007
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None NIH View